Evidence map›Paper›PMID 33932773›Full record

ArticleClinical neurology and neurosurgery2021

The influence of the COVID-19 pandemic on patients with chronic inflammatory demyelinating polyradiculoneuropathy.

Aleksandar Stojanov, Ivo Bozovic, Jelena Stojanov, Aleksa Palibrk, Gordana Djordjevic, Ivana Basta, Marina Malobabic, Ana Azanjac Arsic, Stojan Peric

Open access · greenAbstract read
In one paragraph

Article in Clinical neurology and neurosurgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Aleksandar StojanovNeurology Clinic, University Clinical Centre Nis, Serbia. Electronic address: astojanov1986@gmail.com.
Ivo BozovicNeurology Clinic, University Clinical Centre of Serbia, Belgrade, Serbia.
Jelena StojanovSpecial Hospital for Psychiatric Disorders "Gornja Toponica", Nis, Serbia.
Aleksa PalibrkNeurology Clinic, University Clinical Centre of Serbia, Belgrade, Serbia.
Gordana DjordjevicNeurology Clinic, University Clinical Centre Nis, Serbia; Faculty of Medicine, University of Nis, Nis, Serbia.
Ivana BastaNeurology Clinic, University Clinical Centre of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Marina MalobabicNeurology Clinic, University Clinical Centre Nis, Serbia.
Ana Azanjac ArsicFaculty of Medical Sciences, Neurology Department, University of Kragujevac, Kragujevac, Serbia.
Stojan PericNeurology Clinic, University Clinical Centre of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Univerzitetski Klinički Centar Srbije · RSUniversity of Belgrade · RSUniversity of Kragujevac · RSUniversity of Nis · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAt a time of global health crisis, fear, anxiety, and stress levels increase. The effects of protracted social isolation, and media related misinformation's about the coronavirus disease 2019 (COVID-19) resulting in increased fear/stress related to the insufficiently known illness. The aim was to assess the influence of the COVID-19 health crisis on patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

methodsA cross-sectional study on 29 adult CIDP patients was performed. The Medical Research Council scale was used to evaluate muscle strength. The degree of functional disability was measured using the Inflammatory Neuropathy Cause and Treatment disability scale. The overall quality of life (QoL) was self-estimated on a 0-100 numeric rating scale. We also used a specifically designed 22-question-survey about COVID-19.

resultsRegarding the COVID-19 pandemic, 62% of CIDP patients were concerned. The daily activities of 55% of patients were negatively influenced by the pandemic. During the COVID-19 outbreak, 21% of patients reported their CIDP got worse. In 39% of CIDP patients, the influence of the pandemic on CIDP therapy was reported (reducing the dose or time interval or even discontinuation). The mean value of the self-estimated QoL was 64 ± 19. Independent predictors of worse QoL were age of patients (beta = -0.35, p < 0.05) and fear of the COVID-19 (beta = -0.34, p < 0.05).

conclusionThe COVID-19 pandemic has a significant impact on CIDP patients. Besides the direct influence of the virus and fear of the virus, restrictive measures can indirectly harm the patients with CIDP.

Indexed as

CIDPCOVID-19PandemicPsychological statusStress

Identifiers

PMID33932773
PMCPMC8055522
OpenAlexW3153183349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.